Kidney Disease: Improving Global Outcomes

(redirected from KDIGO)
Also found in: Acronyms.

Kidney Disease: Improving Global Outcomes

,

KDIGO

An international foundation administered by the National Kidney Foundation (U.S.) that aims to foster collaboration in the study of kidney diseases and the dissemination of the best treatment practices through the publication of clinical guidelines.
References in periodicals archive ?
The conference output will include publication of a position statement that will help guide KDIGO and others on therapeutic management and future research.
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Prior to the 2002 publication of the KDIGO criteria for CKD, according to Dr.
However, the KDIGO anemia guideline goes on to state that "individualization of therapy will be necessary as some patients may have improvements in quality of life at Hb concentration above 115 g/L and will be prepared to accept the risks" (KDIGO, 2012 p.
For instance, the ADA guidelines recommend calculating the ACR using a random urine sample, whereas KDIGO recommends a first morning void sample.
KDIGO said its next step is the worldwide implementation of the guideline through its network of implementation Task Force members in 80 countries and in collaboration with local representatives of the International Society of Nephrology.
HIV VHB VHC MONITORES EXCLUSIVOS NO SI CDC (2001): NO SEN (2006): NO KDIG0 (2008) : NO PERSONAL EXCLUSIVO NO SI CDC (2001): NO SEN (2006): PACIENTES CON PCR + KDIGO(2OO8):N0 AISLAMIENTO FISICO NO SI CDC (2001): NO EBPG (2002): UNIDADES CON ALTA PREVALENCIA SEN (2006): PACIENTES CON PCR + KDIGO(20O8):N0 CDC = Centers for Desease Control SEN = Sociedad Espanola de Nefrologia KDIGO = Kidney Internacional Disease Improving Global Outcomes EBPG = European Best Practice Guidelines
Summarize the latest KDIGO recommendations on statin use in patients on hemodialysis
On May 13th Kidney Disease: Improving Global Outcomes (KDIGO) held the first meeting of its Work Group Co-chairs and Evidence Review Team developing the KDIGO Clinical Practice Guideline on Living Kidney Donation.
A large number of clinicians in multiple specialties and subspecialties consider AKI a serious adverse event, and many have implemented protocols to comply with consensus recommendations, including the KDIGO guidelines.
According to the KDIGO anemia guidelines (2012), intravenous (IV) administration of iron is the preferred route for patients receiving hemodialysis.
Governed by its own Board of 50 prominent kidney experts, KDIGO has been managed by the U.